China Proposes New Measures to Optimize High-End Medical Device Regulation
The National Medical Products Administration (NMPA) has released the “Measures for Optimizing Full Lifecycle Supervision...
NMPA
China Tightens Medical Device Quality Oversight: 2025 Inspection Plan Unveiled
China’s National Medical Products Administration (NMPA) has released its 2025 medical device inspection plan, outlining...
China Unveils 2025 Medical Device Inspection Strategy to Tighten Quality Control
China’s National Medical Products Administration (NMPA) convened a pivotal conference in Chengdu on March 24...
China’s 2025 Pharmacopoeia Edition Approved, Set for October 1 Implementation
The Pharmacopoeia of the People’s Republic of China (2025 Edition), released by the National Medical...
NMPA Updates Rules on Domestic Production of Imported Medical Devices
The National Medical Products Administration (NMPA) has released a notification on further adjusting and optimizing...
Acotec Scientific’s Vericor Catheter Wins NMPA Approval for Peripheral Vascular Surgery
China-based Acotec Scientific Holdings Ltd (HKG: 6669) announced that its peripheral disposable support catheter Vericor...
NMPA’s New Guidelines for Drug Registration Review
A Look at the New Rules for Chemical and Biological Drug Filings in China:The Center...
NMPA Seeks Public Feedback on Export Drug Manufacturing Rules
An In – Depth Look at the New Draft Proposal for the Administration and Management...
NMPA Implements Regulatory Reforms for Drug and Medical Device Industries
The National Medical Products Administration (NMPA) has released a notification regarding the implementation of the...
NMPA Releases 89th Batch of Reference Drugs for GQCE Work
The National Medical Products Administration (NMPA) has released the 89th batch of reference drugs for...
NMPA Releases 88th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 88th batch of reference drugs for...
NMPA Releases 87th Batch of Reference Drugs for Generic Quality Consistency
The National Medical Products Administration (NMPA) has released the 87th batch of reference drugs for...
NMPA Proposes Draft for Simplified Registration of Traditional Chinese Medicines from Hong Kong and Macao
The National Medical Products Administration (NMPA) has issued the “Notification on Simplifying the Registration and...
NMPA Releases 85th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 85th batch of reference drugs for...
China’s NHC Launches Pilot Plan to Expand Wholly Foreign-Owned Hospital Sector
The National Health Commission (NHC) has released the “Pilot Work Plan for Expanding the Wholly...
NMPA Drafts Medical Representative Management Measures, Seeks Public Input
The National Medical Products Administration (NMPA) has released the “Medical Representative Management Measures (draft proposal)”,...
Chinese Pharmacopoeia Commission Approves Draft for ChP 2025 Edition
On December 27, the 12th Conference of the Chinese Pharmacopoeia Commission (ChPC) Executive Committee concluded...
NMPA and Local Governments Streamline Drug Approval Processes in China
The National Medical Products Administration (NMPA) has released a notification regarding the pilot work for...
CDE Includes Double-Crane’s Hydroxocobalamine and Sanofi Genzyme’s Fitusiran in Rare Disease Care Plan
China’s Center for Drug Evaluation (CDE) has announced the inclusion of China Resources Double-Crane Pharmaceutical...
NMPA’s CDE Issues Guidelines for Leveraging Real-World Data in Drug Regulation
The Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) has released...